Barriers to the Use of Guardrails On IV Smart Pumps by Williams, Ivory




Barriers to the Use of Guardrails On IV Smart
Pumps
Ivory Williams
University of South Carolina
Follow this and additional works at: https://scholarcommons.sc.edu/etd
Part of the Family Practice Nursing Commons
This Open Access Dissertation is brought to you by Scholar Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized
administrator of Scholar Commons. For more information, please contact dillarda@mailbox.sc.edu.
Recommended Citation
Williams, I.(2017). Barriers to the Use of Guardrails On IV Smart Pumps. (Doctoral dissertation). Retrieved from
https://scholarcommons.sc.edu/etd/4459






Bachelor of Science in Nursing 





Submitted in Partial Fulfillment of the Requirements 
 




College of Nursing 
 






Joan M. Culley, Major Professor  
 
Carolyn Harmon, Committee Member  
 
Lisa Ihnken, Committee Member  
 
Cheryl L. Addy, Vice Provost and Dean of the Graduate School
 
ii 





 I would first like to dedicate this dissertation to the Almighty God! I also 
dedicate this thesis to the late Mr. Allen Cleveland, my grandfather, for your influential 
love in always trusting the universe’s declarations telling you that I would be a successful 
healthcare leader someday. This dissertation is also dedicated to my grandmother, the late 
Mrs. Helen Cleveland, my parents, Mr. and Mrs. Archie and Juanita Thomas, my brother, 
Mr. Antoine C. Williams, my three children, Brian, Topaz, and Romyn, my cousins, my 
aunts, my uncles, and my friends. This work was completed thanks to the humility, love, 




I have thoroughly enjoyed spending countless hours researching and 
accumulating supportive data to defend making positive changes in the areas of 
healthcare. It has been a tremendous, joyous experience to have worked alongside great 
colleagues. I greatly appreciate all of my graduate school professors, in particular Dr. 
Joan M. Culley, and Dr. Carolyn Harmon, for their knowledge, wisdom, persistence, and 
understanding while mentoring me for success as a future healthcare practitioner 
throughout the course of my academic journey. I would like to especially acknowledge 
Dr. Stephanie Burgess, Dr. Abbas Tavakoli, Lisa Ihnken, and Dr. Kenneth Catchpole, for 
supporting and believing in me! Also, JoAnne Herman, I sincerely thank you for your 
dedication, passion, and insightful criticisms as I wrote this manuscript. I wholeheartedly 
appreciate my parents. My mother, Juanita Thomas, for always believing in me and 
reminding me to always let my “little light shine” through the good and the bad. Special 
gratitude goes to my father, Archie Thomas, for uplifting me during the hard times and 
being an exceptional grandfather to my children throughout my journey. I’m humbled 
and grateful for life and my most precious possessions, my three wonderful children, 
Brian, Topaz, and Romyn. I thank God for His patience, empathy, support, and love 




Medication errors involving hospitalized patients have been an evolving challenge 
for decades. Moreover, errors related to intravenous (IV) medication administration 
continue to rise in hospitals despite implemented policies governing the use of 
Guardrails™ for safe IV medication infusion via smart pump technology. An 
organizational investigation was performed to identify barriers to the use of Guardrails™ 
among nursing staff. From 2015 through 2017, multiple interventions that aimed to 
identify barriers and increase nurses’ use of the safety features on IV smart pumps were 
implemented in the hopes of reaching a compliance goal of 90-100%. This quality 
improvement project assesses Guardrails™ compliance with smart pumps since its initial 
integration in 2010 and through 2017. A systematic organizational assessment was 
conducted at a Magnet®-recognized facility in South Carolina to identify the factors that 
influence the use of Guardrails™ by nurses, implement changes based on the assessment, 
measure outcomes, and make recommendations for future change to foster continued 
progress towards the 90-100% benchmark. Participants included all nurses who utilized 
the smart pumps with Guardrails™ (N=2,500). The results provided insights into the 
factors that either succeeded or not through collaboration with numerous stakeholders, 
metrics on Guardrails™ utilization, self-reported IV medication errors per year, and a 
pre- and post-project survey. The project offered valuable information that was used to 
implement changes that eventually resulted in an increase in nurses' compliance with 
Guardrails™ use, provided recommendations for sustaining compliance, and proposed 
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updates to the facility's IV medication administration policy. The data results from the 
Guardrails™ compliance report and IV medication error rate between 2015 and 2017 
provided enough evidence to suggest that a structured continuous education plan is 
essential to increase nurses’ awareness and adherence to policies and procedures 
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Medical errors account for 10% of deaths in the United States (U.S.) every year 
and have now been rated as the third leading cause of death in the U.S. (Sternberg, 2016). 
Medication errors are part of this horrible statistic. One approach to reducing intravenous 
(IV) medication errors is the use of smart pump technology (Association for the 
Advancement of Medical Instrumentation [AAMI] and the Healthcare Technology Safety 
Institute, 2014). The purpose of this quality improvement project was to conduct a 
systematic organizational assessment to identify factors that influence use of 
Guardrails™ safety features by nurses, implement changes based on the assessment, 
measure outcomes, and make recommendations for change. Chapter I provides a 
description of the clinical problem, scope of the problem, clinical environment, analysis 
of clinical problem, the evidence-based practice (EBP) question and the population-
intervention-comparison-outcome-time (PICOT) definitions, and assumptions. 
Description of the Clinical Problem 
In the 1990s, smart IV pump technology began to be used in hospital-specific 
areas (Vanderveen, 2014). IV smart pumps were designed to help prevent IV medication 
errors (Gavriloff, 2012). However, human mistakes continued to occur, directly affecting 
patient safety (Institute for Safe Medication Practice [ISMP], 2013). In 2008, the facility 
decided to adopt the newly innovative IV smart pump technology in an effort to increase 
IV medication safety and improve patient outcomes. In 2010, the facility noticed a 
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significant increase in IV medication errors with 978 IV medication errors. The facility 
contacted the makers of the Alaris® IV smart pumps (e.g. CareFusion®) and 
implemented Guardrails™ safety features into the IV smart pump's drug libraries in April 
of 2010. The Guardrails™ safety features were added to the IV smart pumps to prevent 
IV medication errors. The hospital set a goal that nurses would use the smart pump and 
Guardrails™ safety features 90-100% of the time. Despite implementing Guardrails™ 
safety features, metrics on IV medication errors and Guardrails™ utilization were below 
benchmark, as compliance data revealed that nurses used Guardrails less than 75% of the 
time. Also, there were approximately 1,000 cases of IV medication errors reported 
between 2011 through 2016. Nurses were not using the Guardrails™ safety features on 
IV smart pumps. The question is “why?” 
Scope of Problem 
A number of authors have identified the problem of use of Guardrails™ safety 
features by nurses. Gavriloff (2012) found that nurses used medication safety software 
properly 28% of the time. In addition, Gavriloff (2012) provided evidence that, with 
effective education strategies, staff adherence rates went from 28% to 85% within a 
week. However, education did not prevent errors unless the software was programed 
properly and nurses used the features (Gavriloff, 2012). Sullivan and Palillo (2014) 
identified that of 5780 intensive care units (ICUs) IV smart pump alarms, 7% were 
referencing dose corrections. They concluded that nurses lacked understanding of IV 
smart pump technology that may potentially be influenced by their perceptions, which led 
to incorrect modification of the pump. Rosenkoetter, Bowcutt, Khasanshina, Chernecky, 
and Wall (2008) came to the same conclusion. Perceptions played a large part in the 
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implementation of new technology in hospitals. Harding (2012) called for better 
understanding of how nurses use smart pumps and noted that a distinct culture of non-
compliance existed in hospitals that required rigorous monitoring and education. Harding 
(2012) concluded that the problem may be due to nurses’ lack of understanding of the 
features on smart pumps, hospital policy and procedures related to smart pumps, or 
failure to acknowledge the legal jeopardy when bypassing the IV smart pump drug 
libraries. If patient harm occurs as a result of nurse’s non-compliance with smart pump 
technology, the nurse could be at fault in court proceedings (Harding, 2012). In a study 
conducted by Westbrook, Rob, Woods, and Parry (2011), findings revealed that of 101 
serious IV administration errors, 95 errors resulted from the use of the wrong IV rate. The 
authors identified that routine violations with the use of IV smart pumps stemmed from 
behaviors learned in the workplace (Westbrook, Rob, Woods, & Parry, 2011). 
Alaris® IV smart pumps for the administration of IV medications were initiated 
in the facility in 2008. Two years later, the instances of IV medication errors remained 
high prompting the facility to enhance the smart pumps by upgrading their Guardrails™ 
safety features in 2010 to increase patient safety. Guardrails™ is “a hospital-defined list 
of drugs and concentrations appropriate for use in as many as 15 profiles” 
(Alaris®Guardrails, 2016, p.1). The quality assurance data reported on all self-reported 
IV medication errors and near misses at the facility remained at an all-time high from 
2010 through 2015. In 2011, there were approximately 1500 documented cases of self-
reported IV medication errors within the facility. Also, errors related to IV medication 
administration cost the facility millions of dollars. For example, the facility paid $3.8 
million to five families for injuries that resulted from medication errors (Monk, 2002). 
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The AAMI (2014) postulated that planning ahead and creating an effective plan to 
monitor compliance was highly recommended before integrating systems of infusion 
pumps. Unfortunately, the facility did not establish an effective plan to monitor 
compliance data before smart pumps and Guardrails™ were introduced. In January of 
2015, a hospital-wide electronic survey was sent to all nurses who administered IV 
medications to determine barriers to use of smart pumps with Guardrails™.  In March of 
the same year, the Alaris Guardrails™ Team (AGT) was formed and consisted of two 
nurse managers, a pharmacist, a performance improvement facilitator, a critical care staff 
nurse who joined the team in March of 2016, and two nursing patient facilitators who 
recently joined the team in September of 2016. Their charge was to use the data from the 
survey to identify barriers to the use of smart pumps and Guardrails™ drug libraries by 
nurses and implement needed changes. 
Clinical Environment 
The project will took place at one of only three Magnet® recognized institutions 
in South Carolina. The institution is a 700-bed academic hospital accounting for over one 
million patient encounters per year. There were a total of 7,000 employees, which 
included 750 physicians and 2,500 nurses. In addition, the institution experienced 
approximately 36,114 inpatient encounters and 1,205,066 outpatients encounters every 
year. The project included all 58 inpatient and outpatient units that utilized smart pumps 
with Guardrails™ safety features. There were approximately 740 licensed beds among all 
four hospitals managed by the facility. 
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Analysis of Current Practices 
After analyzing practices implemented when IV smart pumps were integrated at 
the facility, metrics on adherence to Guardrails™ safety features revealed that nurses 
utilized Guardrails™ less than 75% of the time, placing the facility in the 28th percentile 
compared to 764 other institutions that utilized CareFusion® smart pumps technology 
(Dykema, 2015). The data on use of IV smart pumps with Guardrails™ features 
suggested that a more structured process of change was needed. This conclusion 
prompted the institution to develop the AGT charged with implementing interventions to 
increase use of Guardrails™ by nurses. The benchmark set was for nurses to use 
Guardrails™ 90-100% of the time. 
Purpose 
The purpose of this quality improvement project was to conduct a systematic 
organizational assessment to identify factors that influence use of Guardrails™ by nurses, 
implement interventions based on the assessment, measure outcomes, and make 
recommendations for future change in order to foster continued progress toward the 
benchmark set by the facility of 90-100% of the time. 
Theoretical Framework 
The theoretical framework used to guide this quality improvement project was 




Figure 1.1 Kurt Lewin's Change Management Model 
Project Questions 
Prospective questions included 1) as IV smart pump’s Guardrails™ compliance 
rate increases, does self-reported IV medication errors decrease; 2) does the number of 
self-reported IV medication errors decrease with implementation of each intervention, if 
so, what factors significantly impacted increasing compliance rates, and why; 3) 
according to data from the post hospital-wide survey, are there new barriers identified by 
staff nurses, if so, what are these barriers; and 4) does the post nursing survey report an 
increase in staff nurse’s knowledge and awareness regarding proper utilization and 
adherence to IV smart pump’s Guardrails™ policies and procedures. 
EBP Question and PICOT Definitions 
The EBP and the PICOT definitions are based on the format developed by 
Melnyk and Fineout-Overholt (2011). The EBP question is “For hospital based nurses 
using smart pumps with Guardrails™ (P), what are the factors that influence the use of 
smart pumps with Guardrails (I) after implementing interventions based on the 2015 
systematic organizational assessment and hospital-wide survey (C) as measured by the 
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2017 hospital-wide systematic organizational assessment and survey, percent of use of 
Guardrails™ by nurses, and self-reported IV medication errors per month?  The PICOT 
definitions are given in Table 1.1. Other definitions are stated below. 
IV smart pump technology: According to the U.S. Food and Drug Administration 
([FDA], 2014), an IV smart pump is technology that is “equipped with safety features, 
such as user-alerts that activate when there is a risk of an adverse drug interaction, or 
when the user sets the pump’s parameters outside of specified safety limits” (para 6). 
Guardrails™: The Guardrails™ features may also be defined as a “drug library use (that) 
automates programming steps, including drug name, drug amount and diluent volume, 
and activates hospital-based established best practice limits” (Alaris®Guardrails, 2016, 
p.1). Factors: According to Harris (2017) a factor is considered “a circumstance [which] 
contribute(s) to a result” (para 12). For the purpose of this project, the term factors 
include things like interruptions and distractions which impacts or contributes to a result 
(Hughes & Blegen, 2008). 
Table 1.1 PICOT Definitions 
P-Population I-Intervention C-Comparison O-Outcome T-
Time 
Hospital based nurses 
using smart pumps with 
Guardrails™ 
Factors that 
influence the use of 














survey, percent of 
use of Guardrails™ 












This quality improvement project requires active involvement of stakeholders, 
nurses, pharmacy, and unit managers. The quality improvement project assumed that staff 
nurses will actively participate in providing feedback to the survey. In addition, the 
project assumed that nurses would possess commitment to proper use of the smart pumps 





The AGT searched the literature to determine what others had identified as factors 
influencing use of Guardrails™ safety features by nurses. In addition, the AGT searched 
for interventions that had been implemented to increase use of Guardrails by nurses. 
Chapter II contains a description of the search process to include search terms and 
databases, synthesis of the literature, development of the interventions, barriers to 
implementation, and summary. 
Search Process 
The literature search occurred from January 15th, 2016 through March 4, 2016. 
CINAHL Complete, PubMed, Joanne Briggs Institute, Cochrane Library, and Google 
databases were used in the search process. CINAHL Complete was the first database 
searched. 
CINAHL Complete 
CINAHL Complete offered an abundance of articles while using the search terms 
compliance, smart pumps, and guardrails. Each of the search terms was placed in separate 
search boxes, independent of each other. The "text all" option was then chosen for each 
search term. The search option was selected and 268 articles were retrieved; however, 
only eight of the items were selected, as they all pertained to the EBP question. All other 
items were then eliminated because either the title or the article did not relate to the EBP 
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question. The review continued with the CINAHL database and the search term quality 
improvement was used along with the term guardrails. Once more, the "text all" option 
was selected for both terms and 282 articles were recovered. Six of the articles were 
selected because they matched the EBP question. All others were eliminated because they 
were duplicates or did not pertain to the EBP question. During the search in the CINAHL 
database, several terms were used to narrow the search. The search terms used were 
usage, guardrails smart pumps, and assessment. A total of 519 articles were retrieved, but 
none of the articles were used because they were either duplicates or the article did not 
pertain to the EBP question. As the CINAHL search continued, the terms increase 
compliance, guardrails, and smart pumps revealed only two duplicate articles that were 
previously selected. Also, the terms continuous quality initiative, adherence, and smart 
pumps revealed only one article that did not relate to the EBP question. The terms drug 
library, adherence, and nurses revealed 308 articles. Eight were selected while the terms 
IV medication errors and smart pumps together revealed 51 articles with six selected that 
were in congruence with the EBP question. Finally, the terms IV medication errors, smart 
pumps, and Guardrails revealed several articles that included seven duplicates and others 
that failed to support the EBP question. 
PubMed 
The PubMed database revealed 103 articles using the search term of factors that 
influence the use of guardrails. Only 2 articles were eliminated because they were not 
relevant to the EBP question. The term increase guardrails utilization was then used as 
the search option, and 0 articles were retrieved. When the term increase IV drug library 
use was used, 50 articles were identified. Only 1 article matched the EBP question. 
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Finally, the search term increase use of guardrails revealed 51 articles of which 2 
pertained to the EBP question. All others were eliminated because they did not support 
the project or the titles did not match the EBP question. 
Joanna Briggs Institute 
Joanna Briggs Institute was the third search engine used for the review. In 
general, the Joanna Briggs database offered the least amount of information. The first 
terms used in combination were IV medication errors and guardrails, which failed to 
recover any articles. Using the combined terms of IV smart pumps and drug libraries, 
with the publication type of evidence and summaries options selected in the search box, 3 
articles were identified; 1 of which pertained to the EBP question while the others were 
not used. 
Cochrane Library 
The Cochrane Library only offered two articles that pertained to the EBP 
questions. Both articles were retrieved using the combined search terms of smart pumps 
and drug libraries. The terms smart pump, guardrails, nurse compliance to guardrails, and 
guardrail usage were also used and failed to identify any articles. After using all four 
databases, each article that was chosen was thoroughly reviewed, and eight articles were 
recovered from the reference section of randomly selected articles. 
Google Search Engine 
To conclude, the Google search engine was used to explore the FDA, the ISMP, 
and the Alaris CareFusion® websites. Overall, the search process was extensive and 
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identified high-quality information related to the project. The inclusion and exclusion 
criteria is presented below offers a distinct criteria for the articles selected for the purpose 
of this project.  
Inclusion and Exclusion Criteria 
All articles were carefully reviewed for the second selection process. Descriptions 
and quality ratings were assigned based on the evidence evaluation tool adopted from the 
John Hopkins Nursing evidence-based practice model and guidelines (Dearholt and 
Dang, 2012). Throughout the search process, all articles that were related to the EBP 
question were used based on several inclusion criteria. First, articles were selected based 
on the number of times they had been cited and used by others in the literature. Second, 
all articles were chosen if they appropriately supported the EBP question. Third, articles 
that were greater than five years old were used only if they supported the EBP question 
and received high evidence ratings. Last, several articles suggested evaluating and 
reviewing articles that applied to observational continuous quality initiative (CQI) or 
time-motion studies. Exploration of the area of human factors was also mentioned in 
various articles as an aspect to consider when smart pumps were integrated. 
Therefore, several articles on time-motion studies as they related to smart pump 
utilization and increasing guardrails usage were reviewed at random times throughout the 
search process.  These articles were not included in the literature review and synthesis 
because they did not offer significant information to answer the EBP question. Table 2.1 
summarizes the search process to include databases, search terms, number of articles 




Table 2.1 Search Process 
CINAHL  
Search Terms Number of Articles Retrieved Number of Articles Used 
Compliance, smart pumps, guardrails 268 8 
Quality Improvement, guardrails 282 6 
Best practice, infusion safety, guardrails 267 3 
Usage, guardrails, smart pumps 253 0 
Assessment, guardrails, smart pumps 266 0 
Increase compliance, guardrails, smart pumps 2 2: duplicated articles 
Continuous quality initiative, adherence, smart pumps 1 0 
Drug library, adherence, nurses 308 8 
IV medication errors, smart pumps 51 6 
IV medication errors, smart pumps, guardrails 9 7: 7 repeated articles, others did not pertain to PICOT in 
question. 
PubMed 
Search Terms Number of Articles Retrieved Number of Articles Used 
Factors that influence the use of guardrails 2 0 
Increase guardrails utilization 0 0 
Increase IV drug library use 50 1 
Increase use of guardrails 51 2 
Joanne Briggs 
Search Terms Number of Articles Retrieved Number of Articles Used 
IV medication errors guardrails 0 0 
IV smart pumps 0 0 
Smart pump; (with publication type of evidence and summaries  






Search Terms Number of Articles Retrieved Number of Articles Used 
Smart pump drug libraries                                          2                                 2 
Smart pump guardrails                                          0                                 0 
Nurse compliance to guardrails                                          0                                 0 




Synthesis of the Literature 
Content from 27 articles was used in the process of developing the evidence-
based interventions to increase the use of Guardrails™ safety features by nurses. The 
literature was organized according to the approaches or interventions recommended. The 
categories are as follows: smart pump champions and continued quality programs (SPCs 
& CQPs), education (E), organizational culture and medication errors (OC & ME), and 
smart pump evaluation and surveillance methods (SPESM). The SPCs and CQPs 
category included 7 articles while 3 were in the E category, 7 in the OC and ME 
category, and 10 were in the SPESM category. Table 2.2 presents the evidence table by 
category. 
Smart Pump Champions & Continuous Quality Programs 
Patient safety is a priority in hospitals (ISMP, 2013). Orto, Hendrix, Griffith, and 
Shaikewitz (2015) performed a quality improvement project that measured the impact of 
a pump champion program aimed to improve compliance with IV smart pump drug 
libraries over the course of six months. The overall goal of the project was aimed at 
impacting patient safety by decreasing IV medication errors (Orto et al., 2015). Results 
revealed that a smart pump champion program was useful, as the drug libraries' 
compliance rate increased from 83.5% pre-champion implementation to 92% post-
champion implementation (Orto et al., 2015). The AAMI (2014) also suggested that 
facilities adopt and establish a champion when medical devices were implemented in 





Table 2.2 Evidence Table by Category 
Smart Pump Champions/ 
Continuous Quality  
Education Organizational Culture; Medication Errors Smart Pump Evaluation & Surveillance 
Methods 
*Orto, Hendrix, Griffith, & 
Shaikewitz, 2015. 
*AAMI, 2014. 
*Skledar et al., 2013. 
Lee, 2015. 
*Waterson, 2013. 
*ISMP, 2009a: Guidelines for 
smart infusion pumps. 
*Breland, 2010. 




Kirk & Cookson, 2013. 
*Mariani, Cantrell, 
Meakim, & Jenkinson, 
2015. 






Catlin et al., 2015. 
Agyemang & While, 2010. 
Williams, 2015. 
*Ohashi, Dalleur, Dykes, & Bates, 2014. 




*Vitoux, Lehr, & Chang, 2015. 
*IOM, 2011: Standards for developing safe guidelines. 
Wulff, Cummings, Marck, & Yurtseven, 2011. 
*Rothschild et al., 2005. 
Nelms, Jones, & Treiber, 2011. 
*Rosenkoeter, Bowcutt, Khasanshina, Chernecky, & 
Wall, 2008. 
*Tan, Nhi, Kong, MacMillian, & McGain, 
2013. 
*Elias, Moss, Dillavou, Shih, & Azuero, 
2013. 
*Harding, 2012. 
Glickman & Orlova, 2015. 
Elias, Moss, Shih, & Dillavou, 2014. 
ISMP, 2013; Best practice for IV medication 
infusion. 
Vanderveen, 2014. 
*Kirkbride & Vermace, 2011. 
*Goulding & Bedard, 2015. 
*Carlson, Johnson, & Ensign, 2015. 
*ISMP, 2009b; IV medication safety. 
*Manrique-Rodriquez et al., 2012. 
*Montague, Asan, & Chiou, 2013. 
 *Note. All highlighted items were articles with high quality evidence ratings. Articles are grouped by columns based on categories: Smart Pump Champions, Education, 
Organizational Culture, and Surveillance Methods.
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In 2010, Skledar, Niccolai, Schilling, Costello, Minni, Ervin, and Urban (2013) 
initiated a CQI to monitor 6,000 smart pumps in 14 inpatient facilities to increase patient 
safety. Skledar et al. (2013) offered evidence that a smart pump CQI program was useful 
for increasing IV medication administration safety. By posting the hospital's CQI 
findings on the intranet regularly, updating the facilities' smart pump drug libraries on the 
first of each month and as needed, providing staff education as necessary, and identifying 
other issues over the course of three years, the facility's compliance score increased to 
78% (Skledar et al., 2013). 
Implementing smart pumps in hospitals requires assistance from the hospitals' 
stakeholder's, project managers, and pharmacies (Waterson, 2013). Waterson (2013) 
suggested that including hospitals' stakeholders, having a continuous nursing education 
program, and a champion committed to coordinating the smart pumps' information was 
an effective approach. 
Adopting a CQI was important; however, guidelines should be set in place to 
ensure the safe implementation and use of IV smart pumps (ISMP, 2009a). The ISMP 
(2009a) suggested an interdisciplinary team (e.g., nursing champions, a pharmacy, an 
information technology team, biomedical engineers, and infection control) when drug 
libraries are developed. Breland (2010) also performed a CQI from Spring of 2005 
through May of 2006, which included end-user training sessions on April 24th and 25th 
in 2006. The CQI process was used during the planning, implementation, and post 
implementation phases of the project with compliance scores ranging from 33% to 39% 
from November, 2006 through February, 2007 (Breland, 2010). After managing to 
encourage the hospitals' nursing leaders and managers to get on board to express the 
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importance of using the safety software, updating their drug libraries, and providing their 
staff nurse’s real-time feedback, their compliance rate increased to 97% (Breland, 2010). 
On the other hand, Wiest, Longshore, and Harger (2010) implemented a 
medication administration team (MAT) that consisted of nurses, pharmacy staff, and 
information technology team. The team was responsible for implementing smart pumps 
within five hospitals and ensuring that each hospital had sufficient resources to reach a 
compliance goal of 85% (Wiest, 2010). Wiest (2010) reported the initial scores were 68-
88% among the eight hospitals and ranged from 73-93% during the six-month evaluation 
period with the use of the MAT team. Also, Wiest (2010) highly suggested that real-time 
monitoring increased nurses' compliance to using the drug libraries, which improved 
patient safety and medication administration by preventing harm. 
Education 
Understanding the "whys" of using Guardrails™ on smart pumps is important, as 
postulated by Gavriloff (2012). Gavriloff (2012) performed a Deming Cycle that included 
four stages: plan, do, study, and act. The cycle consisted mostly of communication to 
nursing staff on the importance of compliance to using drug libraries (Gavriloff, 2012). 
Gavriloff's (2012) method increased nurses' awareness and adherence to the IV smart 
pump's medication safety software. In turn, it also increased their compliance score from 
85% to 100% compliance. 
Mariani, Cantrell, Meakim, and Jenkinson (2015) performed a simulated learning 
scenario experience for Bachelors of Science in Nursing (BSN)-prepared nursing students 
to assess nurse's perspective when delivering direct patient care. A pre-and post-survey 
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was completed, and students reported that they were more comfortable with providing 
direct patient care more safely after the simulated experience (Mariani et al., 2015). 
Although this study was limited to BSN nursing students, Mariani (2015) suggested 
further research was needed to validate simulated strategies as useful for teaching safety 
and quality in nursing. Dennison (2007) educated nurses on the safety of medication 
administration via computer modules over a six-month period. Dennison's (2007) 
education program suggested that administrative support is imperative for fostering any 
change in staff's behavior with medication administration. Dennison (2007) also suggest 
recruiting an informal champion as a resource for continuous education on medication 
safety administration. 
Organizational Culture & Medication Errors 
For any facility to be successful when adopting and implementing software, all 
stakeholders should be involved with decision making for evaluating, operating, and 
educating staff on the use of the technology (Reston, 2013). An organization's culture and 
hospital-specific practices determined how successful they will be (Reston, 2013). 
Ohashi, Dalleur, Dykes, and Bates (2014) suggested that organizations standardize their 
compliance methods by upgrading and standardizing their drug libraries, thus decreasing 
unnecessary pump warnings since smart pumps were useful for reducing IV medication 
errors, yet look to eliminate end-users' programming errors. Murdoch and Cameron 
(2008) reviewed numerous studies on IV medication errors and smart pumps. The authors 
identified that smart pumps have a significant impact on increasing patient safety by 
preventing programming errors if organizations customize their drug libraries and set 
hard limits on smart pumps (Murdoch & Cameron, 2008). 
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Vitoux, Lehr, and Chang (2015) identified ways in which organizations could go 
about improving the use of their smart pump drug libraries. They strongly suggested that 
the organization's culture, values, and beliefs about practice impact the integration 
process of smart pumps, as it requires a team approach and the availability of a diverse 
variety of stakeholders coming together for the good of collectively integrating 
technology systems and devices to improve patient safety (Vitoux et al., 2015). The 
Institute of Medicine (IOM, 2011) suggested that health care professionals should follow 
all established guidelines and standards set in place at their facilities. Doing so will assist 
in eliminating poor compliance rates and decreasing the risk of IV medication errors 
occurring (Rothschild, Keohane, Cook, Orav, Burdick, Thompson, and Bates, 2005). 
Rothschild et al. (2005) suggested that behavioral factors improved compliance and 
medication safety. On the other hand, Rosenkoeter, Bowcutt, Khasanshina, Chernecky, 
and Wall (2008) suggested considering staff nurse's perceptions on the use of smart 
pumps. In general, organizations should address their culture, their nurse's behavior and 
attitudes, and take a team approach when smart pumps are integrated into their facilities 
(Rosenkoeter et al., 2008). 
Smart Pump Evaluation & Surveillance Methods 
In compliance with the use of smart pump drug libraries, the reason for bypassing 
its safety feature should be measured, and barriers should be identified and removed 
(ISMP, 2009b). Evaluating the use of Guardrails™ on smart pumps is an effective way to 
monitor and identify barriers to its use (Tan, Nhi, Kong, MacMillian, and McGain, 2013). 
Tan et al. (2013) established a smart pump surveillance method, which included the use 
of an auditor to monitor nursing end-user use of drug libraries on IV smart pumps. When 
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nursing end-users were found in noncompliance to the use of drug libraries during the 
auditing period, auditors were required to educate nurses on any concerns regarding the 
use of drug libraries, which also allowed auditors to identify potential barriers to its use 
(Tan et al., 2013). 
Contrarily, Elias, Moss, Dillavou, Shih, and Azuero (2013) suggested 
implementing the evaluation of the use of smart pumps via a simulated environment to 
obtain a much broader understanding of how human factors may impact nurses' use of 
smart pumps. Conversely, Harding (2012) performed a CQI project that incorporated 
monitoring quantitative data from smart pumps while utilizing both nursing staff and 
pharmacy to implement new interventions aimed to increase the use of smart pumps' drug 
libraries. Doing so, Harding (2012) was able to double nurses' use of smart pumps' drug 
libraries over a four-month period. Kirkbride and Vermace (2011) identified ways to 
utilize data reports from their smart pumps to improve clinical practice by standardizing 
all of their smart pumps and developing what they called a parental infusion device 
coordinator (PIDC) to perform routine quarterly reports to email to staff, attending staff 
meetings and annual competencies, and performing compliance rounds to increase 
nursing staff's use of drug libraries. 
Goulding and Bedard (2015) performed a retrospective analysis on drug library 
compliance reports over a five-month period. They identified that it was imperative that 
critical care nurses take part in amending and creating their smart pumps' drug libraries 
and review their CQI reports, to assist with potential education needs, improve their 
clinical practice, and measure outcomes related to medication errors, patient outcomes, 
and cost analysis. Carlson, Johnson, and Ensign (2015) developed a safety score used to 
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evaluate 22 hospitals' use of smart pumps to decrease the number of pump alerts. The use 
of basic infusion mode and the use of hard limits (e.g., end-user’s not allowed to proceed 
with overriding IV medication rate and limits set forth by the institution; ISMP, 2012) 
and soft limits (e.g., end-user has the choice of overriding IV medication rate and limits 
set forth by the institution; ISMP, 2012) were three measures used in Carlson et al. 
(2015) evaluation method. Results revealed that, after adjusting and implementing 117 
new pumps within the facilities, and evaluating trends each month, the overall safety 
scores among the 22 hospitals had improved from 6.41 to 7.57 (Carlson et al., 2015). 
Manrique-Rodríguez, Sánchez-Galindo, Fernández-Llamazares, López-Herce, 
Echarri-Martínez, Escudero-Vilaplana, & Carrillo-Alvarez (2012) were able to identify 
that, after updating their drug libraries, then initiating and analyzing a Guardrails CQI 
event reporter program, their compliance was 87% over of the course of the first four 
months, suggesting that end-user training and readjusting of smart pump limits to 
correspond to clinical practice were warranted. In a different manner, Montague, Asan, 
and Chiou (2013) smart pumps’ surveillance method utilized nursing end user's 
perceptions (e.g. end user’s trust) on the use of smart pumps as an evaluation tool to 
assess how smart pumps may influence nurse use and trust in utilizing the technology. 
Montague’s et al. (2013) research resulted in a trust score of (mean 2.97, SD 1.49), 
indicating that 68% of nurses trusted smart pumps, while 14% did not and 17% were 
neutral. Overall, the recommendation was that smart pump design (e.g. device speed, 
reliability, learnability, noise, alarm, navigation, and automation transparency) influences 




Findings from Hospital-Wide Survey Conducted at the Clinical Site of This Project 
Following review of the literature, the AGT looked at data from the hospital-wide 
survey conducted in January, 2015. All nurses who administered IV medications in the 
hospital system received a survey (N=2,500). The survey contained five questions: What 
is the primary unit that you work on and which of the following are reasons that are 
barriers to your using Guardrails™ safety features on the Alaris® smart pumps? One 
hundred nineteen surveys were returned. Table 2.3, Summary of Hospital-Wide Survey 
Data identifies the specific barriers. 
A variety of authors recommended the use of an implementation team when 
adding smart pumps and drug libraries to a facility. The facility had already formed the 
AGT which included all of the necessary professional groups. Analysis of the data from 
the hospital-wide survey indicated that the majority of nurses (N=85) did not use the 
Guardrails safety features because they could not find the drug or the drug was missing 
from the drug library. This finding is consistent with the literature. In response to the 
survey data, the AGT implemented four interventions designed to improve the use of the 
Guardrails safety features. 
Based on this data, Intervention 1 was the development of a drug library that more 
closely matched those used in the facility and a reorganization of drugs to make them 
easier to find. The AGT realized that maintenance of the drug library needed to be an 
ongoing process. Thirty nurses said that using the technology was tedious and did not 
match the workflow of their unit. Intervention 2 was to acknowledge that the 
organization's culture influenced adoption of technology. The creation of an Alaris 
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Guardrails™ Audit Champions (AGACs) influenced the nursing staff to adopt a culture 
of change within the organization. A few nurses indicated that they did not received 
proper training. Intervention 3 was to add smart pump training to the new employee 
orientation program. Intervention 4 was to establish an effective smart pump 
evaluation/surveillance system while implementing CQI champions. 























responses 63 22 8 9 30 19 
Note. Nurses could choose all that applied. 
Barriers to Implementation 
Changing nurse behaviors in relationship to the use of smart pumps with 
Guardrails™ has the potential to be very challenging. This quality improvement project 
has the advantage of using evidence-based interventions gleaned from the literature. All 
of the stakeholders fully engaged should help in behavior change. Ongoing evaluation 





After determining that the facility's compliance scores on use of Guardrails™ by 
nurses were less than the benchmark in February of 2015, the hospital's stakeholders and 
members of the nursing staff were able to establish the AGT who led the process of 
promoting use of smart pumps and Guardrails™ safety features by nurses. Chapter III 





Chapter III provides information on the methods used to implement the quality 
improvement project. Doing so, the project's design, sample, setting, interventions, 
instruments, procedure, and data analysis were all explored in this chapter. 
Design 
A one sample pre- and post-survey design was used to identify factors that 
influence the use of Guardrails™ since the implementation of various interventions that 
started in 2015. 
Sample 
The project sample consisted of 2,500 nurses who administer IV medications 
using smart pumps with the Guardrails™ safety feature in the facility. All levels of nurse 
education were included except for License Practical Nurses (LPNs). Both male and 
female nurses who work full-time, part-time, and as needed (PRN) participated. All 
travelers who contracted with the institution were excluded, as only core staff were 
included in the project. Managers were not included, and nurses were excluded only if 




The quality improvement project occurred in South Carolina at a facility 
recognized as Magnet®. The institution maintains 58 inpatient and outpatient settings 
that utilize IV smart pumps with Guardrails™. There are approximately 740 licensed 
beds in the four hospitals managed by the facility. 
Interventions 
The AGT was established to develop interventions aimed to increase nurses' 
awareness, knowledge, and adherence to Guardrails™ safety features on smart pumps. 
The interventions were based on evidence from the literature, organizational assessment, 
and data from the hospital-wide survey conducted in 2015. 
Intervention 1 
The AGT added smart pump training to the new graduate and new hire 
orientations. The team also created a Guardrails™ website; placed a quick reference 
guide on the facility's intranet as a resource for staff nurses; and produced Guardrails™ 
education videos. In addition, education workshops were held for both nurses and 
managers at various times throughout the year. 
Intervention 2 
Based on the hospital-wide survey in 2015, the pharmacy re-organized and 
combined the drug libraries for a more customized universal approach that best suited the 
organization's culture and clinical practice. Updates to the drug libraries were done 
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quarterly rather than every six-months. Continuing education, library updates, and 
customization improve compliance (ISMP, 2009a). 
Intervention 3 
According to Orto et al. (2015), a pump champion program is valuable for 
improving nursing compliance to drug libraries, and it is vital that the collaboration be 
done with the hospital's pharmacy leadership, as well as medication safety personnel. The 
AGT piloted a smart pump audit champion on an adult critical care unit to assess the 
feasibility of implementing an audit champion throughout the entire facility. The audit 
champion performed three to five audits on nurses' adherence to Guardrails™, and 
ensured nurses entered the correct unit identifier (ID) number into the smart pumps for 
appropriate data retrieval for the pharmacy. The champions were selected for both the 
day and night shift and were responsible for auditing a total of 15 smart pumps per week. 
The champion's role also consisted of educating nurses on the importance of using 
Guardrails™ and reinforcing the significance of placing the unit's ID number into the 
smart pumps. Monthly data reports were projected to be given to each unit's manager, 
who would emphasize the legal liabilities associated with being noncompliant to 
Guardrails™ on smart pumps. The pilot was a success, and the champions provided 
useful feedback, suggesting the use of a paperless audit tool, and decreasing the number 
of audits collected every week. Finally, the Alaris® Guardrails Audit Champions 
(AGAC) were established and rolled-out throughout various areas within the facility, 




Intervention 4  
Continuous monitoring by the AGAC and Guardrails™ compliance data were 
performed monthly. Adjustments to the audit process were based on feedback from each 
area's champion and their managers before reassessing the need to roll-out to the next 
consecutive area each month. Overall, the current audit process positively impacted 
nurses' awareness and adherence to Guardrails™ on smart pumps. 
Instruments 
Outcomes were measured using a hospital-wide survey developed by the facility 
based on the survey distributed in 2015, informal interviews with several key 
stakeholders, Guardrails™ data percentage compliance rates retrieved monthly from 
CareFusion®, but aggregated as yearly statements on self-reported IV medication errors  
and near miss data reports retrieved from the institution's quality department and 
extracted into Excel® software. 
Hospital-Wide Survey 2017 
The Hospital-Wide Survey 2017 was created using the Redcap software. 
Therefore, “this project was supported by NIH/NCRR Colorado CTSI Grant Number 
UL1 RR025780. Its contents are the authors’ sole responsibility and do not necessarily 
represent official NIH views” (Harris, Taylor, Thielke, Payne, Gonzalez, Conde, 2009, 
para 4). Redcap offers a variety of analytical options for interpreting the inquiry results. 
All information from the survey was collected in Redcap and held under strict security 
and confidentiality. Both the project's author and a statistician had full access to the 
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survey results in Redcap. The Redcap software allowed survey response to be completely 
anonymous by selecting the Public Survey Link under the Manage Survey Participant 
option to ensure responses were kept anonymous, and blinded to the projects’ 
investigators. Participants were invited to take the survey via email, and the information 
received from each survey response was automatically downloaded into the Redcap 
software. 
The Hospital-Wide Survey 2017 was extracted in whole from the inquiry 
conducted in 2015. The same survey used in 2015 was also used in 2017 for appropriate 
comparison. The 2015 survey contained five questions. The first question asks the 
participant to identify the unit they primarily work on. The second question asks the 
participants to check all the barriers that apply to the use of Guardrails safety features on 
smart pumps. There were six barriers: The drug is not in the library, I cannot find the 
drug I need, There is no time/it is tedious, There is no training/education, and 
Guardrails™ do not match the work flow. Participants had the option to choose all that 
apply, and respond with comments to any of the six barriers. 
Feedback from the survey was provided to hospital administrators and nursing 
staff. The responses received from the survey provided insights to make appropriate 
recommendations for the institution. Thank you notes were sent out to everyone from the 
original email list after the survey closed. 
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Interviews with Stakeholders  
Throughout the course of the project, several key stakeholders were informally 
interviewed at various times. Those interviewed included a nursing informatics director, a 
human factor engineer, and a pharmacist. The nursing informatics director was shadowed 
for five months during the project. The interview with the informatics director was 
informal, and all information obtained from the director was used as a reference for 
contacting other key leaders needed to collect appropriate data to assess how smart 
pumps and Guardrails™ were used at the facility. 
Second, a human factor engineer was interviewed. Again, the interview was 
informal. Inquiries regarding barriers to nurses' use of Guardrails™ on the smart pump 
were addressed. Significant information was obtained, and factors such as body 
mechanics, age, height, device malfunction, and the overall design of the user interface 
were identified as potential barriers to the use of smart pumps. Finally, the pharmacist 
interviewed was a member of the AGT and provided pertinent information about the 
history of smart pumps at the institution and information on data collection on 
Guardrails™ usage. 
Percentage of Guardrails™ Usage 
The proportion of Guardrails™ usage by nurses was captured every month from a 
measuring tool used by CareFusion®, the makers of the Alaris® pumps. CareFusion® 
sends data to the institution based on their Guardrails™ usage as compared to other 
facilities that use smart pumps from CareFusion®. The tool supplies the facility with a 
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monthly count of infusions using the Guardrails™ Suite MX and those not using the 
Guardrails™ Suite MX. The information is captured, and a percentage of usage score is 
calculated. The reports were sent to the pharmacy department every month, and 
pharmacy would run the reports via the hospital's web server. Later, the pharmacy would 
send the information to the AGT. 
Self-reported IV Medication Errors  
The quality department collected information on medication errors and near 
misses as they were all self-reported by staff at the facility through the hospital's patient 
safety net (PSI) reporting portal. The data retrieved from the reporting tool was converted 
using Excel® software for review as needed. Reports from the application provide data 
monthly. For this project, however, compliance reports were obtained monthly, but 
aggregated as yearly accounts. 
Procedure 
The procedure for this quality improvement project is described below. First, the 
institutional review board was notified about the quality improvement project to obtain 
valid institutional approval. Second, interventions 1-4 were implemented over a 2-year 
period. Third, one week before the survey was distributed, managers were instructed by 
the hospital’s Assistant Chief Nursing Officer (ACNO) to reinforce to staff nurses the 
importance of taking the survey to gain a high response rate to take part in the survey. 
Since Sunday was the start of the work week at the facility, the survey was sent 
out on the following Friday, September 15, 2017. The survey was made available for 
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voluntary participation for 2 ½ weeks to ensure all staff nurses would have allocated 
enough time to complete the survey. The participants were encouraged by their unit’s 
manager to complete the survey before the 2 ½ weeks deadline. All participants were sent 
a friendly reminder on the Sunday after the survey opened that states, “work with the 
survey will be ending soon, please complete the survey and send, thank you.” The 
rationale for taking the survey was provided to each participant and presented at the 
beginning of each survey invitation. Instructions presented in the survey offered 
information, suggesting that the nine-question survey will take less than five minutes to 
complete, and feedback from the survey will assist in making the medication 
administration safer at the facility. In effort to thank all the participants that were invited 
to take part in the survey, a "thank you" note was broadcasted via email to all participants 
from the original email list after the survey closed. Completed surveys were 
automatically downloaded to the Redcap software where the results were analyzed. 
Interviews 
Several stakeholders were informally interviewed at various times throughout the 
quality improvement project. First, a pharmacist was interviewed and used as a reference 
at different intervals throughout the project. The pharmacist was asked to provide data on 
Guardrails™ utilization, information on medication administration times/schedules, and 
information on the historical evidence pertaining to the initiation of smart pumps at the 
facility. The pharmacist also volunteered information about their wireless system and 
how data from the smart pumps is captured from each unit monthly. The pharmacist 
indicated that the institution lacks an effective strategy to capture the data from specific 
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units. Therefore, it was difficult to track compliance information from each unit. Thus, 
the creation of a AGACs served as a resource for nurses on the unit. The AGACs 
assessed 10-15 smart pumps per week to verifying that both Guardrails™ and the correct 
unit number are programed into the smart pumps. The AGAC then placed the information 
collected during their visual inspection into the facilities audit tool available online via 
Verge software. The AGAC also served as a direct resource for educating nurses on the 
importance of adherence to Guardrails™ and placing the unit’s number into the smart 
pumps. Overall, communication with pharmacy had been ongoing via email as questions 
about the project evolved.  
The nurse informatics director was then interviewed. The informatics leader was 
shadowed for a course of five months during the project. The informatics director served 
as a resource for allocating information needed from various stakeholders in the facility. 
The informatics director offered a broader insight into the cost analysis associated with 
smart pumps and how cost played a major role in setting priorities in the institution. The 
informatics leader insisted that due to the facilities' current priorities, the decision to 
purchase the pump-integrated system with the smart pump connected to electronic health 
record (EHR) was not a feasible solution for the institution at this time. Integration of the 
smart pumps into the EHR offered the facility a solid solution to the automatic extraction 
of unit-specific smart pump data for tracking and auditing instead of having nurses 
manually program their unit-specific ID number into the smart pumps. This would enable 
the pharmacy to create unit-specific compliance reports. 
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Lastly, a human factor engineer was also informally interviewed. The engineer 
offered new insightful information on the use of smart pumps. The engineer identified 
potential human factors that are barriers to the use of Guardrails™. Factors include the 
age and height of the nurse that potentially contribute to the efficient use of the smart 
pumps. Other factors include malfunction of the smart pump devices and the design of 
the user interfaces on the smart pumps. The three members interviewed were beneficial 
with providing information needed to complete this project. 
Data Analysis 
The data allocated for this project included results from both the 2015 and 2017 
surveys and Guardrails™ compliance data rates compared to self-reported IV medication 
errors from 2015 to 2017. A one-sample t-test was used to analyze and compare both the 
2015 and 2017 survey results. The outcome was measured from 2015 to 2017, and 
Guardrails™ usage rates and self-reported IV medication errors were compared using a 
two-sample portion z-test. The information collected and analyzed in this quality 
improvement project offered a systematic organizational assessment to identify factors 
that influence the use of Guardrails™ by nurses, so that recommendations for future 
change could be made in order to foster continued progress toward the benchmark set by 





Chapter IV presents the results from the practice improvement project. The EBP 
question that guided this project was, “For hospital based nurses using smart pumps with 
Guardrails™, what are factors that influence the use of smart pumps with Guardrails™ 
after implementing interventions based on the 2015 systematic organizational assessment 
and hospital-wide survey as measured by 2017 hospital-wide systematic organizational 
assessment and survey, percent of use of Guardrails™ by nurses, and self-reported IV 
medication errors per month. Both the 2015 and 2017 surveys were created and 
administered using Redcap software. After the survey closed, all data were downloaded 
to Excel® and analyzed using SAS statistical software (version 9.4). 
Descriptive statistics were used to analyze and interpret data collected from the 
project. Barriers to use of Guardrails™ with smart pumps from the 2015 survey were 
compared to barriers reported in the 2017 survey following the interventions. 
Self-reported IV Medication Errors  
Data on self-reported IV medication error were collected from the institutions 
quality department and downloaded for analysis into Excel® software. SAS analysis was 
used to compare nurses’ use of Guardrails™ before (2010-2014) and after
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(2015-2017) the interventions. A z-test was used to analyze the data. The p-value was 
significant at.00001. The proportion of nurses using Guardrails™ on smart pumps was 
significantly higher (.81) after the interventions than before (.71). Table 4.1 presents 
these data. 
In 2008, IV smart pumps were integrated at the facility to decrease the risk of IV 
medication errors. In 2010, there were approximately 978 reported cases of IV 
medication errors at the facility (Figure 4.1). In addition, Figure 4.1 shows data on the 
count of self-reported IV medication errors recorded from 2010-2017. Guardrails™ were 
then added to the smart pumps in April of 2010, with a compliance goal set at 90-100%. 
However, the facility identified that nurses’ used Guardrails™ less than 75% of the time 
(Figure 4.2). 
Use of Guardrails™ 
Data on Guardrails™ utilization rates were collected from pharmacy and exported 
to Excel® and yearly utilization rates were calculated. A yearly account of Guardrails™ 
utilization scores is displayed in Figure 4.2. Guardrails™ utilization scores continued to 
decline in 2011 and 2012. Scores averaged 69% (Figure 4.2). In 2013, scores averaged 
74% and 75% in 2014. The practice improvement project began in 2015. As of 
September 2017, the average utilization rate of Guardrails™ was 88% for the year, and 
90% for the month. 
Guardrails™ utilization and self-reported IV medication errors were reported 
from 2010-2017 were captured using Excel® analytical tools. The information was 
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generated based on yearly averages of both Guardrails™ utilization and accounts of self-
reported IV medication errors by year. The report revealed that in 2011, self-reported IV 
medication errors had reached its peak of 1529 reported cases compared to low 
Guardrails™ utilization score of 69% (Figure 4.3). 
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Figure 4.2 Yearly Account of Guardrails™ Utilization Scores 
Figure 4.3 Guardrails™ Utilization and IV Medication Errors 2010-2017 
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In contrast, by 2015 there were 1108 reported cases of self-reported IV 
medication errors, and Guardrails™ utilization scores averaged 76% (Figure 4.3). 
Guardrails™ utilization increased by 10% in 2017 and self-reported IV medication errors 
decreased. There were 235 reported cases of self-reported IV medication errors as of 
March 2017 (Figure 4.3). A retrospective view of Guardrails™ utilization over-time is 
displayed in Figure 4.4. Figure 4.4 also illustrates Guardrails™ utilization before and 
after the AGT initiated the practice improvement process in March of 2015. Utilization 
scores averaged 74%-75% in 2014 before the AGT was established in 2015, while 
current compliance scores as of September 2017 averaged 88%. 
2015 Pre-Survey Data 
The pre-survey was conducted in January of 2015 (N=119). The data collected 
from this survey provided insights on barriers to nurse’s use of Guardrails™ on smart 
pumps. Figure 4.5 illustrates the proportion of participants who completed the survey 
based on specific nursing areas. Question 2 on the survey asked, “What unit do you 
primarily work on?” Data collected from the responses to question 2 were categorized 
using themes based on all nursing areas identified in the survey. Codes were established 
in Table 4.2. The codes created in Table 4.2 were used to interpret various data 
throughout this project. Each category were identified based on responses from the 
survey. Themes were created as they related to the specific areas in each category. Each 
code, MS, C, M, I, S, and P, represents its corresponding nursing area listed from each 
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theme (e.g., MS= All Medical/Surgical Floors, C= Critical Care, M= Meduflex Float 












Table 4.2. Key for Nursing Areas 
Survey Key for Nursing Areas 
Category Theme Code 
Cardiovascular, GI, Renal/Transplant, 
Oncology, Neurology, Ortho, Stepdown 
units, Transitional Care units,  All Medical/Surgical Floors MS 
ED, PACU, all Adult ICU’s Critical Care C 
Critical Care both Pediatrics and Adults, 
Med/Surg. Floors Meduflex  M 
Infusion Cancer Center Infusion Center   I 
Transplant Infusion, Senior Care Unit, 
Heart and Vascular Prep/Recovery, Cath 
Lab, Interventional Radiology, Adult 
Cardiovascular Clinic Specialty Areas S 
Pediatric ICU’s, Special Care Nursery, 
Mother Baby, Med/Surg. units Pediatrics P 
*Note. GI= Gastroenterology, ED =Emergency Department, PACU =Post Anesthesia Care Unit, ICU = 


















Figure 4.4 Guardrails™ Utilization Over Time 
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The percentage of nurses who completed the survey from various nursing units is 
presented in Figure 4.5. The information in Figure 4.5 reveals that of 119 participants, 
50% (n=60) were from various Medical/Surgical nursing areas both impatient and 
outpatient. Twenty percent (n=24) were from Critical Care, 8% (n=10) were from the 
Infusion Cancer Center, and 12% (n=14) were from various Specialty care areas, and 7% 
(n=8) were from Pediatrics. Results from the pre-survey are presented in Table 4.3 as a 
frequency table. Question 3 of the pre-survey identified barriers to nurses’ use of 
Guardrails™ by providing each participant six check all that apply options. 
There were (N=119) responses, 52.94% (n=63) of participants agreed that drugs 
are not available in the library, 18.49% (n=22) agreed that they have trouble finding the 
drugs in the drug libraries, 6.72% (n=8) agreed that they don’t have enough time/using 
Guardrails™ is tedious, 7.56% (n=9) agreed that they never received training or 
education on using Guardrails™, 25.21% (n=30) agreed that existing Guardrails™ 
setting did not match their workflows in their work areas, and 15.97% (n=19) agreed 
there were other issues which prevented them from utilizing the Guardrails™ features. 
Survey questions 4, 5, and 6 extended from question 3 of the survey and provided 
the option for participants to write-in comments. Question 4 in the pre-survey asked, “If 
you selected, I am having trouble finding the drugs I need in the different Guardrails™ 
libraries, please tell us which drug(s) you are having trouble finding and which libraries 















Table 4.3 2015 Pre-Intervention Barriers 










and the drug I 
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I am having 
trouble 
finding the 
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I don’t have 
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N           % 
No 56             47.06 97           81.51             111              93.28 110       92.44  89        74.79 100       84.03 
Yes 63            52.94 22          18.49      8                 6.72  9           7.56  30        25.21 19        15.97 
 
 










































Nursing Areas with Written Responses to 
Question 4
All Medical/Surgical Floors Critical Care Meduflex -both P/A
Infusion Cancer Center Specialty Areas Peds- both cc/floor
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Only 58 participants provided comments on survey question 4. Sixty percent 
(n=35) were from Medical/Surgical Floor areas, 19% (n=11) were from Critical Care 
areas, 3% (n=2) were from Meduflex areas, 7% (n=4) were from Infusion Cancer Center 
areas, and 10% (n=6) were from all inpatient and outpatient Specialty areas. There were 
(n=0) written responses to question 4 from Pediatrics areas. The information captured in 
Table 4.4 was extracted in whole based on participants written responses to question 4. 
Each nursing unit responses were categorized by areas and codes were established for 
each unit. The legend for Table 4.4 is illustrated in Table 4.2. 
Question 5 from the survey asked, “If you selected I have looked/asked and the 
drug I need isn’t in the Guardrails™ library, and please tell us which drug is/are 
missing.” Information pertaining to question 5 evoked several key responses. The data 
presented in Figure 4.7, reveals all survey participants who responded in written form to 
question 5 (n=15). There were 73% (n=11) responses from participants in 
Medical/Surgical Floor areas, 13% (n=2) from Critical Care areas, and 13 % (n=2) from 
all Specialty areas. There were no responses from Pediatric, Infusion Cancer Center, or 
Meduflex nursing areas. All written responses to question 5 were extracted in whole and 
displayed in Table 4.5 based on nursing areas. Table 4.2 provides a legend to identify 
each nursing unit code. 
Question 6 asked, “If you selected other, please tell us what any other barriers to 
using Guardrails™ are?” Of the 19 responses, 47% (n= 9) written comments were from 
participants on the Medical/Surgical Floors areas, 21% (n=4) from Critical Care areas, 
5% (n=1) from Infusion Cancer Center areas, 16% (n=3) from Specialty areas,  
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Banana bag w/ thiamine 
Keppra 
Keppra, citate for CRRT 
Lots of ab1, some chemo drugs 
Magnesium. Also, mag given for resp distress should be 2g in 15 minutes; for mag 
replacement, should be 1-2 hours 






Ab1, drugs that need to be titrated, and chemo regiments like cytarabine and cyto1an 
Can't remember 
Dose appropriate - cyto1an, cytarabine - I have to program outside of the soft stop for 
most non-RCHOP/BMT uses 















Ab1 - will try to remember which one and write down 
Ab1 but can't remember the name 
Alteplace for IR lytics (dose usually 1 mg/hr - drug, 5 mg/250mL bag, 50 mL/hr). Also, 
alteplase for use with EKOS system. Drug concentration 10 mg in 250 mL run at 25 
mL/hr. This is per manufacturer of EKOS machine due to the low flow and high 
pressure needed to push the TPA to the clost. EKOS coolant of normal saline also needs 
to run at 35 mL/hr. 
Can't remember 
Certain chemo regimens 
De1amethasone, ondansetron, bolus fluids 
DHE 
DHE and some ab1 
Don't remember 








Ondansetron (zofran), ceftria1one (Rocephin); I would recommend adding common 











Adenosine gtt for FFR 
Alteplase 
Alteplase for EKOS 















Written Response to Survey Question: 5 
 
C 
I don't see any trouble with the library, I just don't like the pumps period. They 










Azactam is not in peds critical care <20 kg 
Due to previous e1perience  
IV levetiracetam, 0.45% sodium chloride 
Keppra 
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Nursing Areas with Written Responses to 
Question 5
Figure 4.7 Percent of Written Responses to Pre-Survey Question 5 
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and 11% (n=2) from Pediatric areas, which includes both intensive care and 
medical/surgical Pediatric nursing areas (Figure 4.8). The information displayed in Table 
4.6 was extracted in whole and includes all written comments from question 6. Table 4.2 
provides a legend to identify each nursing unit code. 
2017 Post-Survey 
Data collected from the post-survey used both Excel® and SAS (version 9.4) to 
analyze the query. There were 155 responses to the 2017 post-survey. Unlike the pre-
survey, the post-survey included three questions on demographics one question to assess 
the facilitys’ current 2017 AGAC process. Like the pre-survey, question 2 of the post 
survey asked, “What unit do you primarily work on?” The data results were then 
analyzed using SAS frequency tables. Again, all data collected from questions which 
contained a written response were categorized using themes based on nursing areas, and 
codes were created from each unit theme (Table 4.2). There were 153 total responses to 
question 2. 
The data reported in the Figure 4.9 reveals that of 153 responses, 45% (n=69) of 
survey respondents were from all Medical/Surgical areas, 23% (n=36) were from Critical 
Care areas, 7% (n=10) were from Infusion Cancer Center areas, 1% (n=2) were from all 
other Specialty nursing areas, which included both inpatient and outpatient, 7% (n=10) 
were from all Pediatric nursing areas, and 17% (n=26) were from the Meduflex areas. A 


























Don't reply to me 
It can be tedious for basic fluid admin. And it takes all thinking out of med admin, 
which is detrimental to nursing skill development. 
When a patient is crashing, I have to change over the IV pump settings to Critical 
Care versus Med Surg patient. When trying to set up vasopressors this delay with 
having to reset the pump is an issue. 
When patients have multiple bags of potassium ordered, for the sake of continuity 
and keeping infusions running, I would like to be able to program a primary 
potassium infusion and piggy back a second bag of potassium as a secondary 
infusion. Alaris will not let you set primary potassium and secondary potassium, you 
have ot set a primary basic infusion and a secondary potassium infusion to run 2 bags 
continuously over 2 hours without interruption. 
 
I 










After you select medication, you have to manually plug in dose, volume, and rate - 
I've seen other hospitals have common drugs plugged in with dose,     volume, and 
rate 
At times the ordered dose is outside Guardrails 
Have had issues with IV abx not used often on the unit 
I am unsure if our pumps received the wireless update sent over the past few weeks 
I have issues with secondary infusions and being able to set Guardrails. Also, maybe 
some education on making sure we are choosing the right fluids. Lastly, TPN, the 
dextrose is translated to % of dextrose on bag and in MAR, but on pumps it's in 
grams/mL. I don't know how to convert that and most often the number I think it 
would be isn't available on the selected list. 




P No barriers 
 
S 
Have been using basic infusion due to IV being for hydration only 
No issues 











 Infusion Cancer Center
Specialty Areas
Peds- both cc/floor
Nursing Areas with Written Responses to 
Question 6




Table 4.7 Demographic Variables 
Variables  Post-Survey 
(N=155) 
 














































*Note. All percentages in this table were reported from SAS analysis (version 9.4) and rounded to its 







2017 POST-SURVEY RESPONSE BY 
NURSING AREAS
All Medical/Surgical Floors Critical Care Infusion Cancer Center
Specialty Areas Peds-both cc/floor Meduflex-both P/A
Figure 4.9 2017 Post-Survey Response by Nursing Areas 
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Question 3 in the 2017 post-survey asked, “What is your current level of 
education?” Figure 4.10 displays the distribution of education from the 153 respondents. 
Twenty percent (n=30) held an Associates in Nursing, 72% (n=110) held a Bachelors in 
Nursing, and 8% (n=13) held a Graduate degree in Nursing. A description of the second 
demographic variable from question 4 of the post-survey is presented in Figure 4.11. 
Question 4 asked, “Years of nursing experience?” Data revealed that there were 154 
responses, with 56% (n=86) having 0-5yrs. of nursing experience, 23% (n=35) with 6-
11yrs. of nursing experience, 10% (n=16) with 12-17yrs. of nursing experience, and 11% 
(n=17) with 18+ yrs. of nursing experience. Age was the last demographic variable 
assessed in the post-survey. 
Figure 4.12 represents information extracted from responses to question 5 of the 
post-survey assessment. There were 155 responses, and data revealed that 27% (n=42) 
were 18-28yrs. of age, 43% (n=66) were 29-39yrs. of age, 19% (n=30) were 40-50yrs. of 
age, 10% (n=15) were 51-61yrs. of age, and 1% (n=2) were 61+yrs. of age. The 
frequency table presented in Table 4.8 reports information obtained from question 6 in 
the 2017 post-survey. Question 6 from the post-survey asked nurses to identify barriers to 
use of Guardrails™ by providing each participant six check all that apply options. Of the 
155 responses, 35.48% (n=55) of participants agreed that drugs are not available in the 
library, 10.32% (n=16) agreed that they have trouble finding the drugs in the drug 
libraries, 12.26% (n=19) agreed that they don’t have enough time/using Guardrails™ is 
tedious, 3.87% (n=6) agreed that they never received training or education on using 
Guardrails™, 11.61% (n=18) agreed that existing Guardrails™ settings did not match 
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LEVEL OF NURSING EDUCATION 
Figure 4.10 Level of Nursing Education 




0-5yrs. 6-11yrs. 12-17yrs. 18+yrs.
































                               Table 4.8 2017 Post-Intervention Survey 










the drug I need 






N             % 
 
I am having 
trouble finding 
the drugs I need 






N                %            
 
I don’t have 








N                 % 
 































N           % 
No 100        64.52 139         89.68 136         87.74 149       96.13 137      88.39 114     73.55       






There were 40 responses to question 7 presented in Figure 4.13. Question 7 asked, 
“If you selected I am having trouble finding the drugs I need in the different Guardrails™ 
libraries; please tell us which drug(s) you are having trouble finding and which libraries 
you use.” Results revealed that 48% (n=19) of nurses from all Medical/Surgical areas, 
25% (n=10) from Critical Care areas, 20% (n= 8) from Meduflex areas, 5% (n=2) from 
the Infusion Cancer Center areas, 0% (n=0) from Specialty areas, and 3% (n=1) from 
Pediatric areas provided written responses to question 7 (Figure 4.13). All written 
responses to survey question 7 were extracted in whole and presented in Table 4.9. The 
codes for each nursing unit category presented in table 4.9 is displayed in Table 4.2. 
Question 8 from the post-survey also required participants written responses. 
There were 27 written responses to survey question 8. Results illustrated in Figure 4.14 
provides a description on all written responses by nursing unit areas. There were 44% 
(n=12) written responses from Medical/Surgical areas, 26% (n=7) from Critical Care 
areas, 26% (n=7) from Meduflex area, 4% (n=1) from the Infusion Cancer Center, and 0 
responses from both Pediatrics and Specialty areas. All written responses to survey 
question 8 were extracted in whole and presented in Table 4.10. The codes for each 
nursing unit category presented in table 4.10 is displayed in Table 4.2. 
Responses by nursing areas are displayed in Figure 4.15. Question 9 asked, “If 
you selected other, please tell us what any barriers are to using Guardrails™.” There were 
43 written responses. The information from Figure 4.15 reveals that 42% (n=18) of all 
written responses to question 9 were from all Medical/Surgical areas, 33% (n=14) from 


























Nursing Areas by Written Responses to Question 
7
Figure 4.13 Percent of Written Responses to Post-Survey Question 7 
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I can't remember 
In pacu we frequently use ansethsia settings for drips, they are frequently not 
avalible in nursing libraries 
kcentra 
Mainly IVF such as plasmalyte and things like that  
n/a 
NA 
Several antibiotics - I always report this to my pharmacist 
Standard and mixed IVF choices are minimal and/or confusing to select. When 
it takes 60+ seconds to program/find a simple IVF, I am MUCH less likely to 
use the guardrail settings for this infusion. 
 
I 
clinical trial drugs; new drugs just on market, olaratumumab, a couple of 
others but cannot recall specifically at this time.  











I don't recall. I always use the guardrails. But if I don't it's because I can't find 
the drug. It has been a long time since that has happened  
n/a 
Not sure 
several; can't remember which ones 
this is the only reason i would not use the guardrails, i always use them 
because of a mistake i made about 8 years ago. 
MS Adult Med/Surg library; albumin 
Albumin for liver patients, rate not defined 
antibiotics; chemotherapies 
Blood Products 
chemo drugs not present in Adult guardrail library 
Desmopressin, adult drugs  
I am able to find most of the drugs I need 
I cant recall now but it has happened a couple of times. Search by name  
I can't remember exactly.... I think it was a sodium/dextrose combo. 
I dont recall 
I dont remember 
I have trouble deciding which category to look under for the drug/fluid I am 
about to hang 
I use the Oncology library. If we have to administer chemo on other floors 
(ICU, cardiology) they need their own cardiology setting 
IV guardrail drugs, Keppra 
IVF's  
n/a 
past in time problem, cannot remember the name of the drug  
There have been maybe one or two, I can't remember now. It has been a long 
time. 
Use Oncology library. Our medications that have multiple drugs in them are 
not listed; such as Ondansetron and Dexamethasone or Etoposide, 
Doxorubicin & Vincristine. 

























































don't remember at this time 
For everything I hang I look in the guardrails, if I dont see it I look a second time then 
hang the med as basic. I can't think of any off the top of my head. 
I do not remember. rarely have this issue. 
n/a 








As listed above. 
can't remember the actual drug name 
Can't remember; it's been awhile since this has happened. 
chemo drugs not present in Adult guardrail library 
D5 1/2NS + additive 
Desmopressin 
I am able to find most of the drugs I need 
idk 
mix drugs ( zofran and decadron) for example 
Phenergan occasionaly on certain brains 






















 Infusion Cancer Center
Specialty Areas
Peds- both cc/floor
Nursing Areas by Written Responses to Question 9
Figure 4.15 Percent of Written Responses to Post-Survey Question 9 
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Center areas, 2% (n=1) from Specialty nursing areas, and 0 responses from Pediatric 
areas. All written responses to survey question 9 were extracted in whole and presented 
in Table 4.11. The codes for each nursing unit category presented in table 4.11 are 
displayed in Table 4.2. 
The final question from the 2017 post-intervention query reports data related to 
the facility’s current 2017 AGAC process, and accounts on staff nurses participation with 
the smart pump champions on their nursing units. Question 10 in the post-survey asked, 
“Have you had the opportunity to work with the Alaris Guardrails™ Audit Champions on 
your unit or any other nursing units?” There were 148 responses, with 76% (n=113) 
reporting they had not work with the Alaris Guardrails™ Audit Champions, and 24% 
(n=35) reporting that they had worked with the Alaris Guardrails™ Audit Champions 
(Figure 4.16). 
Analysis of Pre and Post-Survey 
Several frequencies and t-tests were performed in SAS (version 9.4) to assess for 
differences among the pre and post-survey, and differences amongst each demographic 
variable (e.g. level of education, years of nursing experience, and age) compared to 
barrier choices listed in question 3 of the pre-survey and question 6 of the post-survey 
(e.g., barrier 1: I have looked/asked and the drug I need isn’t in the Guardrails™ library, 
barrier 2: I am having trouble finding the drugs I need in the different Guardrails™ 
libraries, barrier 3: I don’t have enough time to use Guardrails™/using Guardrails™ is 
tedious, barrier 4: I didn’t receive training or education on using Guardrails™, barrier 5: 
Existing Guardrails™ settings don’t match with workflows in my area, barrier 6: other). 
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correct concentration of drugs not in pump 
Habit 
I am unaware this is protocol or at least don't recall receiving education about it being 
required. Does it have to be for meds other than IVF or for everything on a pump? Is it 
required? ALSO, it is the responsibility of the RN to update the patient's weight daily so 
they receive the right amount of drugs - I FREQUENTLY see this not being done. This is 
especially important for BP, cardiac, and sedation meds and should be addressed ASAP. 
I have not experienced any barriers  
I have only found one drug not in library. I always us 
i use it most of the time. 
I use the guardrails with drips, but for MIVF, find it more of a hassle to search for fluid 
rather than just use basic infusion 




Only running antibiotic and it's not available as primary option 
some drugs don't have same concentrations or calculations used in unit 
h 
 I use guardrails if the drug isn't listed, I send a message to have it updated 
I don't have trouble using the guardrails, I use them consistently as long as the medication I 
need is listed 




I use guardrails if the drug isn't listed, I send a message to have it updated 
I don't have trouble using the guardrails, I use them consistently as long as the medication I 
need is listed 





air in line 
I always use the library  
I don't have any barriers to Guardrails, I don't use IV pumps often or in pressure situations 
I don't have barriers to guardrails currently, all drugs I have mentioned have been added 














all of the drugs we give are in the Alaris pump 
I always use guardrails, occassionally may change rate depending on access but have not 
had any issues 
I do not have any issue or barriers with the guardrails  
I do not work with the Alaris pumps often, and do not find many barriers to their use. 
I don't have any barriers. I always use guardrails.  
I don't really have trouble using it. 
I have been able to use the Guardrails library without difficulty 
i have no barriers 
I have no issues using the guardrail library 
I have no issues with Guardrails 
I typically use the guardrails features 
I've had very rarely used 'basic infusion' on med/surg units. 
N/A 
None of the above, I have received proper training and use the guardrails appropriately.  
none, I use them all the time 
patient specific needs ie-chf & vanco @ 250 ml/hr 750ml bag 
Tedious  
s 










The frequencies of variables compared in the pre and post survey is presented in 
Table 4.12. The information in Table 4.12 shows the frequency distribution of barriers by 
pre and post-intervention. The p-value for the chi square test was .0038 for barrier one, 
.0526 for barrier two, .1276 for barrier three, .1830 for barrier four, .0033 for barrier five, 
and .0375 for barrier six as presented in Table 4.12. The results showed about 35.48% 
(n=55) of post intervention looked/asked and the drug was not in Guardrails™ library as 
compare to pre intervention about 52.94% (n=63) (p value=.0038), 11.61% (n=18) of 
post-intervention existing Guardrails™ settings don’t match with workflows as compared 
to pre-intervention about 25.21% (n=30) (p value=.0033), and 26.45% (n=41) of post- 
intervention identified that there were other barriers to the use of Guardrails™ as 
compared to pre-intervention about 15.97% (n=19)  (p-value =.0375). All other barriers 





Opportunity to Work with 
the Alaris Guardrails Audit 
Champions? 
Yes No




                               Table 4.12 Frequency Distribution of Barriers by Pre and Post-Interventions 
           
  Variables*                                        Pre-Survey (N=119)                                                           Post Survey (N= 155)      




1. I have looked/asked and the drug 























2. Iam having trouble finding the 























3. I don’t have enough time to use 























4. I didn’t receive training or 






















5. Guardrails settings don’t match 










































The frequency distribution of barriers by level of nursing education is displayed in 
Table 4.13. The p-value for the chi square test was .8282 for barrier one, .3244 for barrier 
two, .1759 for barrier three, .4008 for barrier four, .6025 for barrier five, and .1744 for 
barrier six as displayed in Table 4.13. The chi square test for all p-value results were 
>.05, which indicated there were no significant differences among the level of nursing 
education on barriers. 
The frequency distribution of barriers by years of nursing experience is displayed 
in Table 4.14. The p-value for the chi square test was .0876, for barrier one, .1611 for 
barrier two, .1097 for barrier three, .5157 for barrier four, .1875 for barrier five, and 
.1744 for barrier six as presented in Table 4.14. The results revealed no significant 
differences exist between years of nursing experience and barriers to Guardrails™ usage. 
The frequency distribution of barriers by age is displayed in Table 4.15. The p-
value for the chi square test was .0581 for barrier one, .0432 for barrier two, .3989 for 
barrier three, .9592 for barrier four, .0847 for barrier five, and .2242 for barrier six as 
displayed in table 4.15. The results showed a p-value < .05 for barrier two (p-
value=.0432), suggesting there is enough evidence to support that differences exist 
between the age of nurses and trouble with finding the drugs in different Guardrails™ 
libraries. The post-intervention barriers by age showed about 18.18% (n=12) of 
participants 29-39yrs, and 9.52% (n=4) of the participants 18-28yrs, post-intervention 
had trouble finding the drugs in the different Guardrails libraries (p-value=.0432). All 




                            Table 4.13 Frequency Distribution of Barriers by Level of Nursing Education 
Post-Survey (N=153)          Associates       Bachelors   Graduate  p-value 
Variables* N % N % N % 
1. I have looked/asked and 









































2. Iam having trouble 
finding the drugs I need in 









































3. I don’t have enough time 
to use Guardrails/using 









































4. I didn’t receive training 

































5. Guardrails settings 
don’t match with 






























































                          Table 4.14 Frequency Distribution of Barriers by Years of Nursing Experience 
Post-Survey (N=154)  









Variables* N % N % N % N % 
1. I have looked/asked and the 


















































2. Iam having trouble finding 






















































3. I don’t have enough time to 
use Guardrails/using 















































4. I didn’t receive training or 






































5. Guardrails settings don’t 













































































































Barriers N % N % N % N %   N % 
1. I have looked/asked, and 








































































2. I am having trouble 
finding the drugs I need in 




























































3. I don’t have enough time 
to use Guardrails/using 





























































4. I didn’t receive training 















































5. Guardrails settings don’t 






















































































The information presented in Chapter IV was analyzed to identify factors that 
influenced the use of Guardrails™ by nurses. The findings indicated that all but one 
demographic variable (e.g. age) were related to identified barriers. All nurses 
regardless of education, time in the workforce, and age identified similar barriers to 
use of Guardrails™ on smart pumps. There was a correlation between IV medication 
errors and use of Guardrails™. The higher the percentage of use of Guardrails™ the 
lower IV medication errors.  Although the facility did not meet the benchmark, data 
indicated that the interventions did increase the use of Guardrails™ from 63% to 
88%. It will be vital for the AGT to establish a plan for continuous quality 





The purpose of this quality improvement project was to conduct a systematic 
organizational assessment to identify the factors that influence the use of Guardrails™ by 
nurses, implement interventions based on the assessment, measure outcomes, and make 
recommendations for future change in order to foster continued progress toward the 
facility’s goal set at 90-100% Guardrails™  use. The project used a descriptive approach 
to conduct an organizational assessment. The project included all nursing units with staff 
nurses who utilized Guardrails™ on IV smart pumps in their daily workflows. All 
statistical information collected for this project was analyzed using SAS statistical 
software (version 9.4) and Excel® software. The SAS (version 9.4) analysis software was 
used to analyze frequencies, using the t-test to compare results from the 2015 pre-survey 
and the 2017 post-survey. Frequencies, the t-test, and z-scores were also used to analyze 
and compare Guardrails™ compliance data and self-reported IV medication errors. 
Excel® was used to categorize data from the “primary working unit” variable to identify 
themes and formulate codes for each area of nursing; doing so allowed a visual 
presentation of the frequency of responses from each nursing area. Tables and graphs 
were also created in Excel® to display the results. 
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Implications of Findings 
The data results from the Guardrails™ compliance report and self-reported IV 
medication errors between 2015 and 2017 provided enough evidence to suggest that a 
structured continuous education plan is essential to increase nurses’ awareness and 
adherence to policies and procedures governing the use of Guardrails™ on IV smart 
pumps. The data collected in this project was assessed and the information obtained 
offered reasonable answers to each of the four prospective questions mentioned in 
Chapter I. 
Question One 
The question of whether a relationship existed between Guardrails™ compliance 
and self-reported IV medication errors  were  probed by asking, “As IV smart pump’s 
Guardrails™ compliance rate increases, does the rate of IV medication errors decrease?” 
Data revealed that as the IV smart pumps Guardrails™ compliance rate increases, the rate 
of IV medication errors decreases, having z-test results with a p-value less than .00001. 
The p-value was significant and suggested that the proportion of nurses using 
Guardrails™ was high post interventions (.81), compared to pre-intervention (.71), which 
also implies that as Guardrails™ compliance increased, self-reported IV medication 
errors decreased. The literature has emphasized that a structured continuous education 
program is beneficial when smart pumps are first implemented in hospitals. The evidence 
strongly suggests that in order to foster increased compliance scores, collaboration with 
hospital stakeholders, pharmacy, nurses, unit managers, and information technology, 
forming unit champions, and establishing a continuing education program are all essential 
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elements that directly impact Guardrails™ compliance and improved patient safety 
outcomes. 
Question Two 
The second question postulated in Chapter I asked, “Does the number of IV 
medication errors decrease with the implementation of each intervention? If so, what 
factors significantly impact increasing compliance rates and why?” The institution 
incorporated several change processes to increase their nurses’ awareness, adherence, and 
compliance to Guardrails™ on smart pumps. The facility updated their drug libraries 
each quarter to allow sufficient time for new drugs to be added to their smart pumps, 
added education on the use of Guardrails™ for new hires and new nurses’ orientation, 
consolidated their drug libraries for a universal approach to Guardrails™ use and 
features, offered educational workshops, quick reference guides, re-organized their drug 
libraries, and implemented an audit champion initiative in order to assist with increasing 
staff nurses’ knowledge, awareness, and adherence to the safety feature on smart pumps. 
Beginning in 2015, interventions implemented throughout the course of this project and 
positively contributed to an increase in Guardrails™ compliance, which decreased the 
rate/risk of IV medication errors. The data reported that a correlation exists between 
Guardrails™ usage and IV medication errors. 
Recognizing the correlation between Guardrails™ usage and self-reported IV 
medication errors answers the question of whether the number of IV medication errors 
decreases as Guardrails™ compliance increases, but how it was impacted by 
implementation of each intervention cannot be determined. However, the factor of 
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“awareness” contributed to a decrease in IV medication errors, since all interventions 
directly impacted nurses’ awareness to utilize Guardrails™ on smart pumps. Hence, 
increasing Guardrails™ usage is regarded as an effective preventive measure to decrease 
IV medication errors.  As a result, monitoring monthly Guardrails™ compliance data as 
yearly reports, compared to the yearly accounts of self-reported IV medication errors, 
offered the institution a means to assess their progress towards the 90-100% benchmark, 
assess their current policies and procedures on the use of Guardrails™ on smart pumps, 
and offered them guidance with decision making on any future interventions that needed 
to be made moving forward. 
Question Three 
The third inquiry from Chapter I addressed data on new barriers to the use of 
Guardrails™ that were reported from the post-survey. The question asked, “Are there any 
new barriers identified by staff nurses, and if so, what are these barriers?” The 2017 post-
survey offered an array of data to assess and determine if new barriers on the use of 
Guardrails™ existed post-implementation of all the various interventions from 2015-
2017. For example, 26.45% (n=41) of the nurses assessed post-intervention identified 
that there were other barriers to the use of Guardrails™, as compared to 15.97% (n=19) 
of them pre-intervention (p-value =.0375), which suggested other barriers were 
identified. All data captured as written comments in the post-survey suggested that there 
were new barriers. For example, three participants, all from the Critical Care areas, 
reported each statement presented below. 
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“I am unaware this is a protocol or at least don't recall receiving education about 
it being required. Does it have to be for meds other than IVF or for everything on a 
pump? Is it required?” 
“I have only found one drug not in library. I always use it most of the time.” 
“I use the guardrails with drips, but for MIVF, find it more of a hassle to search 
for fluid rather than just use basic infusion.” 
All the comments presented above suggest that the new barriers include unclear 
policies and procedures governing the use of Guardrails™, drugs being missing from the 
libraries, and interference with workflows. The information revealed that it is worthwhile 
to update policies governing IV medication administration, for the pharmacy to quickly 
update new medications as they become readily available for use on smart pumps, and 
reinforce saying “no to basic infusion” while emphasizing the importance of correctly 
using the IV technology for the effective and compliant use of Guardrails™ in all nursing 
areas. In addition, all significant p-values in the post-surveys’ chi-square test was .0038, 
which suggests that about 35.48% (n=55) of the nurses, post-intervention, looked/asked 
and the drug was not in the Guardrails™ library, compared to 52.94% (n=63) of nurses 
pre-intervention (p-value=.0038). Approximately 11.61% (n=18) of the post-intervention 
agreed that Guardrails™ settings did not match with their workflows, as compared to 
25.21% (n=30) pre-intervention (p-value=.0033), and 26.45% (n=41) of the nurses 
assessed post-intervention identified that there were other barriers to the use of 




The last question from Chapter I asked, “Does the post-nursing survey report an 
increase in staff nurses’ knowledge and awareness regarding the proper utilization and 
adherence to the IV smart pump’s Guardrails™ policies and procedures?” The data 
reported in this project suggest that incongruences may exist with nurses’ awareness of 
the proper utilization and current procedures on the use of Guardrails™ (see reports from 
Question Three). Also, the results presented in Figure 4.16 report that regarding 
awareness of the current procedure surrounding implementing an Alaris Guardrails™ 
Audit Champion on all nursing units hospital-wide, 76% (n=113) of the 148 respondents 
reported that they had not had the opportunity to work with the audit champions and 24% 
(n=35) reported that they had worked with the audit champions. The information 
gathered suggest that nurses are aware of this new procedure governing the use of 
Guardrails™. 
Limitations 
There were several limitations identified in the project. First, the application of 
using a survey tool presented biases, such as the risk of participants providing untruthful 
answers, the risk of data error occurrences with some respondents who did not respond, 
and the risk of participants misinterpreting the “yes” and “no” questions. Second, similar 
demographic data should have been used in both surveys to offer broader insights on 
variations that may have existed among the variable “age” and all barriers pre- and post-
interventions since the frequency distribution of post-intervention barriers by age showed 
about 18.18% (n=12) of participants 29-39yrs, and 9.52% (n=4) of the participants 18-
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28yrs, post-intervention had trouble finding the drugs in the different Guardrails libraries 
(p-value=.0432). Third, it could not be determined if the same participants who 
participated in the pre-survey also participated in the post-survey; having the same 
participants in both surveys could have increased the reliability of the results. Also, there 
was a low response rate for both the pre-survey (N=119) and post-survey (N=155). Even 
so, the post-intervention survey had a higher response rate, which was partially due to 
having the hospital’s ACNO present the post-survey to unit managers and their nursing 
staff as compared to the pre-survey, which was presented by members of the AGT. 
As a result, incorporating a more creative plan to engage staff to participate in 
surveys is warranted since higher response rates offer fewer non-response biases.  
However, using the same survey for both the pre- and post-interventions was beneficial 
for identifying any new barriers to the use of Guardrails™, identifying a need to make 
any new changes to current interventions intended to increase nurse use of Guardrails™ 
on smart pumps, and offering significant information on the overall progress of the 
current interventions. 
Implications for Nursing 
Guardrails™ were added to the smart pumps in 2010 to assist with lowering the 
risk of IV medication errors. There were several self-reported cases of IV medication 
errors within the facility even after Guardrails™ were added. The institution failed to 
establish an effective education and compliance monitoring plan when the smart pumps 
were integrated, and nurses failed to use the safety features on smart pumps. Both nursing 
leaders and nursing staff need to understand the purpose of the safety features on smart 
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pumps as well as the policies and procedures governing their use. Nurses need to be 
aware that compliance with Guardrails™ supports adhering to the five rights of IV 
medication administration; in this case, the “right dose/rate” will be established when 
Guardrails™ are in use. 
When continuous educational initiatives are implemented in facilities, continual 
support from hospital leaders is essential, because staff tend to participate more readily 
when stakeholders are included in initiatives. Patient safety is always the first priority, so 
nurses need to understand the true value of using Guardrails™ on smart pumps despite 
fostering a culture of workarounds. Nursing leaders need to emphasize that it is 
imperative that staff nurses understand how to correctly operate the IV smart pump 
technology and utilize its safety features because it decreases the risk of IV medication 
errors and improves patient safety and outcomes when used properly. In order to ensure 
that Guardrails™ compliance data are captured from each nursing unit when nursing staff 
are required to enter a specified unit ID number into the smart pumps for appropriate data 
retrieval, nursing leaders need to establish an effective method to share each unit’s ID 
number with all nursing staff, specifically Meduflex float pool nurses, in the event that 
they would need to float to other units. Ongoing education on the use of Guardrails™ on 
smart pumps is necessary for hospital facilities. 
More importantly, all information summarized in this quality improvement 
project provides nursing stakeholders with the opportunity to address their reported 
compliance rates by emphasizing legal liabilities if there’s an issue of noncompliance 




Smart pumps are smart when nursing end-users are properly trained on utilizing 
the technology to administer IV medications. Also, nursing end-users need to make the 
right decision to use the appropriate library within the smart pump’s safety features. 
Failure to comply with the safety features increases the risk of IV medication errors, 
which runs the risk of harming or even killing a patient. However, when policies are not 
accurately set in place to govern certain procedures within facilities, and failing to 
establish an effective education and compliance monitoring plan upon integrating smart 
pumps, the staff will lack support and education regarding making the right decisions. As 
a result, questions arise regarding the procedure and patients are put at risk.  
Therefore, nursing leaders need to collaborate with hospital stakeholders and their 
quality departments to re-assess policies governing IV medication administration. IV 
medication administration policies need to reflect evidence-based data on the use of smart 
pumps with Guardrails™. Nursing leaders need to also ensure that Guardrails™ drug 
libraries are continuously updated as formulary changes are made, and establish an 
effective plan of sharing each units’ ID number with all staff nurses, especially Meduflex 
(float pool nurses) in the event that they would need to float to other units. 
Establishing an effective on-going education plan and monitoring monthly 
Guardrails™ compliance data compared to self-reported IV medication error occurrences 
are important matters to consider when smart pumps are used in hospitals. A systematic 
organizational assessment was conducted to identify barriers to nurses’ use of 
Guardrails™ on smart pumps. The project demonstrated that when barriers to the use of 
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Guardrails™ are identified, addressing those issues are just as important as nurses 
complying with the safety features of smart pumps. When issues pertaining to drug 
libraries are presented by nursing end-users and if they are not addressed, the issue of 
noncompliance to Guardrails™ will continue, self-reported IV medication errors will 
increase, and the risk of harming a patient will also increase. This project demonstrated 
that implementing various structured education processes and informational initiatives 
that aim to increase nurse’s knowledge, awareness, and adherence to Guardrails™ on 
smart pumps has a positive impact on increasing compliance scores, decreasing IV 
medication errors, and improving patient safety. 
The collection of various comments from the survey participants suggest that 
nurses have a great deal to say regarding Guardrails™ usage at the facility. Therefore, 
nursing leaders should conduct informal interviews with nursing end-users, as doing so, 
may offer further insights on barriers to the use of Guardrails™. 
Conclusions 
Adherence to Guardrails™ on smart pumps, ensuring that the drug libraries are 
updated frequently, and sharing each units ID number with all staff nurses, especially 
Meduflex (float pool nurses) in the event they would need to float to other units is 
warranted. Doing so, increases Guardrails™ compliance scores, decreases IV medication 
errors, and improves patient safety. However, nurses still fail to utilize the safety features. 
The evidence collected in this project provides data that support establishing an organized 
education program that aims to identify barriers to nurses’ use of Guardrails™ and 
increase nurses’ use of Guardrails™ in order to increase compliance scores over time. In 
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2010, the facility identified that nurses were utilizing Guardrails™ safety features <75% 
of the time. The facility then took the initiative to identify why the issue of 
noncompliance was occurring, implemented various interventions based on their 
findings, measured outcomes from their interventions, and finally adopted a continuous 
educational audit process that supported the hospital's culture. All interventions had a 
positive impact on increasing the institutions’ averaged yearly compliance scores from 
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